JPMorgan will arrange a share exchange for Biodexa (BDRX), leaving ordinary shares unchanged.
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
Biodexa Pharmaceuticals Plc announced a 1-for-8 depositary share exchange for its American Depositary Shares (ADSs), effective around October 26, 2026. This change means one new ADS will represent 400 ordinary shares, up from the previous 50, while the company's ordinary shares themselves remain unaffected. JPMorgan Chase Bank, N.A. will facilitate the mandatory exchange, with no fractional ADSs being allocated.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.